Evaluation of Mitochondrial Dysfunction in Severe Burn and Trauma Patients

NCT ID: NCT01812941

Last Updated: 2021-05-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-09-30

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this project is to evaluate the level of mitochondrial dysfunction several patient populations: Burn, trauma, and control group of healthy volunteers.

Study hypothesis: Increased plasma concentrations of a newly discovered inflammatory mediated, called mtDNA DAMPS associated with the occurrence of multi-organ dysfunction syndrome in severly injured patients.

As the severity of a burn injury or trauma injury increase, so will systemic mitochondrial dysfunction.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Increased plasma concentrations of a newly discovered inflammatory mediated, called mtDNA DAMPS associated with the occurrence of multi-organ dysfunction syndrome in severly injured patients.

A normal healthy sub-population will be used as a control.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Burns Trauma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Burn: blood collection

Procedure: Blood draws as the intervention.

Group Type OTHER

Burn: blood collection

Intervention Type OTHER

blood collected at designated time intervals

trauma: blood collection

blood to be collected at different time intervals. Blood draw as the intervention

Group Type OTHER

trauma: blood collection

Intervention Type OTHER

Blood samples collected at certain timepoints. Time points for burn/trauma subjects: Day0,Day1,Day2,and Day6 and Day7.

healthy volunteers: blood collection

Blood draws as the intervention

Group Type OTHER

healthy volunteers: blood collection

Intervention Type OTHER

blood collected at designated time intervals

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

trauma: blood collection

Blood samples collected at certain timepoints. Time points for burn/trauma subjects: Day0,Day1,Day2,and Day6 and Day7.

Intervention Type OTHER

healthy volunteers: blood collection

blood collected at designated time intervals

Intervention Type OTHER

Burn: blood collection

blood collected at designated time intervals

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Burn injury must be less than 24 hours old at time of initial sampling
* Burn must be 2nd or 3rd degree and at least 10% TBSA
* ISS (injury severity score) \> 15

Exclusion Criteria

* Burn injury/trauma injury \> than 24hours old at time of initial sampling
* Burn \< 10% total body surface area.
* Evidence of active infection on admission in the burn subjects.
* \< 19 years of age and \> 70 years
Minimum Eligible Age

19 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of South Alabama

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jon Simmons

Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jon Simmons, MD

Role: PRINCIPAL_INVESTIGATOR

University of South Alabama, Department of Surgery

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of South Alabama Medical Center

Mobile, Alabama, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jon Simmons, MD

Role: CONTACT

251-471-7971

Mark Gillespie, PHD

Role: CONTACT

251-460-6497

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jon Simmons, MD

Role: primary

251-471-7971

Mark Gillespie, PHD

Role: backup

251-460-6497

References

Explore related publications, articles, or registry entries linked to this study.

Simmons JD, Lee YL, Mulekar S, Kuck JL, Brevard SB, Gonzalez RP, Gillespie MN, Richards WO. Elevated levels of plasma mitochondrial DNA DAMPs are linked to clinical outcome in severely injured human subjects. Ann Surg. 2013 Oct;258(4):591-6; discussion 596-8. doi: 10.1097/SLA.0b013e3182a4ea46.

Reference Type DERIVED
PMID: 23979273 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

11-212

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.